Should You Buy Greenlane Holdings, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Greenlane Holdings, Inc. (GNLN) presents a moderate quality profile with a QOC score of 4.1/10. Trading at $2.75, separating genuine undervalued opportunities from value traps is essential, as detailed by our model data.
The short answer: 1 of 1 CirclFi valuation models project upside for Greenlane Holdings, Inc. (GNLN) at $2.75 — the model consensus leans bullish, with a Quality Score of 4.1/10 and Value-Trap risk of 65/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Greenlane Holdings, Inc. (GNLN) in 2026?
What Is the Bull Case vs the Bear Case for Greenlane Holdings, Inc. (GNLN)?
| Bull case — $5.96 target (+116.7%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, 1 of 1 models identify upside from $2.75 to a median fair value of $5.96, indicating the market hasn't fully priced in Greenlane Holdings, Inc.'s earnings power. | No active model flags significant downside for GNLN. The Value Trap score of 65/100 still argues for some caution. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $5.96 (+116.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. |
How Does GNLN Compare to Its Tobacco Peers?
Valuation data pages: HCMC · GRLF · RYM · TPB · KAVL · RLX · PM · CHUC · ISPR
Which Other Stocks Score Like GNLN on Quality?
Closest companies to GNLN’s Quality of Company score of 4.1/10, across all industries.
- PTN — Palatin Technologies, Inc. (QOC 4.1) · analysis
- HCTI — Healthcare Triangle, Inc. (QOC 4.1) · analysis
- ARTL — Artelo Biosciences, Inc. (QOC 4.1) · analysis
- STRG — Starguide Group, Inc. (QOC 4.1) · analysis
- TENX — Tenax Therapeutics, Inc. (QOC 4.1) · analysis
- KXIN — Kaixin Holdings (QOC 4.1) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Greenlane Holdings, Inc. (GNLN) Worth Buying in 2026?
Greenlane Holdings, Inc. at $2.75 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 4.1/10, and the median fair value of $5.96 implies +116.7% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Greenlane Holdings, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About GNLN Stock?
Should I buy GNLN stock right now?
Based on CirclFi's multi-model analysis, 1 of 1 models see upside for GNLN at $2.75. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 4.1/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Greenlane Holdings, Inc.?
Key risks include: an elevated Value Trap score of 65/100, suggesting apparent undervaluation may mask deteriorating fundamentals; a below-average Quality Score of 4.1/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Tobacco companies. Always diversify and consult a financial advisor.
How does GNLN compare to its competitors?
Among Tobacco peers, GNLN holds a Quality Score of 4.1/10. Comparable companies include HCMC (QOC 4.3), GRLF (QOC 3.6), RYM (QOC 4.5). The relative ranking helps investors identify whether GNLN offers better fundamental quality than alternatives in the same sector.
Is GNLN a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. GNLN's Quality Score of 4.1/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy GNLN at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $5.96 to $5.96. At $2.75, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for GNLN.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad